The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pulmonary edema, noncardiogenic (NCPE)
Publications
Transfusion-Related Acute Lung Injury After Immunoglobulin Infusion for Kawasaki Disease: A Case Report and Literature Review.
Global pediatric health 2017;4;2333794X17746545 — 2017 — 2333794X17746545
Multiorgan Failure From Cryoglobulinemic Vasculitis Following Intravenous Immunoglobulin Replacement Therapy.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2016 Dec;22;441-443 — 2016 Dec — 441-443
Transfusion-related acute lung injury after transfusion of pooled immune globulin: a case report.
Transfusion 2014 Dec;54;3088-91 — 2014 Dec — 3088-91
Transfusion-related acute lung injury after the infusion of IVIG.
Transfusion 2001 Feb;41;264-8 — 2001 Feb — 264-8
Acute pulmonary edema as a complication of anti-snake venom therapy.
Indian journal of pediatrics 2001 Jan;68;81-2 — 2001 Jan — 81-2
Noncardiogenic pulmonary edema triggered by intravenous immunoglobulin in cancer-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Nephron 1997;77;368-70 — 1997 — 368-70